AKT1 and Mental deterioration: We found that EA therapy was beneficial in improving cognitive decline by promoting glucose uptake in the hippocampus and that the underlying molecular mechanisms might be associated with phosphorylation of Tau protein through the AKT/GSK3β signaling pathway.